A plate-based high-throughput assay for virus stability and vaccine formulation.
about
Hepatitis A virus and the origins of picornaviruses.Structure of Ljungan virus provides insight into genome packaging of this picornavirus.Picornavirus uncoating intermediate captured in atomic detailNeutralizing antibodies can initiate genome release from human enterovirus 71More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesStructure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine designStructure of human Aichi virus and implications for receptor bindingAdditives for vaccine storage to improve thermal stability of adenoviruses from hours to monthsRaman spectroscopic signatures of echovirus 1 uncoating.Structural Basis of Human Parechovirus Neutralization by Human Monoclonal Antibodies.Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.Ammonia as an In Situ Sanitizer: Influence of Virus Genome Type on Inactivation.Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus.Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site.Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection.SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased ThermostabilityIn vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.Hydrophobic pocket targeting probes for enteroviruses.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.Impact of reducing and oxidizing agents on the infectivity of Qβ phage and the overall structure of its capsid.Practical Approaches to Forced Degradation Studies of Vaccines.Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody.The Effect of Heat on the Physicochemical Properties of Bacteriophage MS2.A Novel Open and Infectious Form of Echovirus 1.Interactions between Enteric Bacteria and Eukaryotic Viruses Impact the Outcome of Infection.Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71.Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate
P2860
Q27317117-CA3CB708-0838-4488-B1E9-63D5A62DF483Q27322662-DFD6414E-A534-4DC3-9E9D-F41C98D932F7Q27678469-88B207DC-BBE0-4F5D-B58A-342EDF024921Q27681480-5454F9C9-DF48-45E0-9345-3982A36DDB27Q27681644-38143E8A-6E5D-4DB6-AA17-1A692B475C16Q27702186-CB9955C8-384B-4082-B7C9-FAB4BB1203F4Q27727995-C5C582C7-3E68-48D5-8482-33DCFBAD929BQ27980656-2685FA23-2177-4E12-8F72-74F87B3423E5Q30362789-BED14B25-7420-4348-BB5D-DF4E71FE4EBDQ34484165-8212A90E-480E-4A24-8393-38D1397686BAQ35975620-A8A42F04-2253-44F5-AA3A-9284DE31BF50Q36086365-C2B3AE1C-57AE-438D-BEE8-519DECE7EEBCQ37142337-8E8E5C4F-9D3B-495F-A6FE-88A47B8B4774Q37576028-82D6AA52-5547-4E4A-B3E7-4C3DD61779F8Q37612504-8CA66E25-D5C2-4590-B3C2-5612D6DAC7BCQ37618759-6A904DF8-4D8E-48C1-B81D-1277A6CB6BCFQ38744534-00456CA9-54F5-4096-A839-9A8669F1C765Q38776761-5E112630-F1A6-4682-812A-C6805BBEA4E0Q38784217-A26F4855-AC5A-458C-835A-AC78B5AE0A60Q38829970-4FCABB09-A393-4826-89FA-A14D3D976382Q38851217-3261E39C-9CEB-4128-80DB-6758B8C7BDE5Q39611595-18DD63FB-2C52-444A-885C-41D7E2515D11Q39852643-E8364173-73CE-499C-BD4F-C9288BE894B3Q40052398-BE96F7F5-CA58-41E1-85D9-1BA3CDD2C4DCQ40469437-8E5AAC40-C189-4A9D-8273-3D28C07D3855Q40668556-3F766C38-3A23-44CE-A1F4-2F3B929E2885Q47558073-A300AF86-553F-469F-84C2-6BA57CB3A99CQ55518522-1F25D98B-7E05-4A08-8296-DE208C458264Q58717985-5BDAC45F-9C6B-4D55-8543-97D44D8F1C3BQ58747407-2A0B8F38-7F7D-4352-A220-CF1B7F8A37B8
P2860
A plate-based high-throughput assay for virus stability and vaccine formulation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A plate-based high-throughput assay for virus stability and vaccine formulation.
@en
A plate-based high-throughput assay for virus stability and vaccine formulation.
@nl
type
label
A plate-based high-throughput assay for virus stability and vaccine formulation.
@en
A plate-based high-throughput assay for virus stability and vaccine formulation.
@nl
prefLabel
A plate-based high-throughput assay for virus stability and vaccine formulation.
@en
A plate-based high-throughput assay for virus stability and vaccine formulation.
@nl
P2860
P50
P1476
A plate-based high-throughput assay for virus stability and vaccine formulation.
@en
P2093
Tobias J Tuthill
P2860
P304
P356
10.1016/J.JVIROMET.2012.06.014
P577
2012-06-26T00:00:00Z